Literature DB >> 4027398

Reversible cardiac arrhythmia in a breast cancer patient treated with recombinant alpha interferon.

S Martino, B A Samal, Y H Sahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4027398     DOI： 10.1007/bf01806028

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  9 in total

1.  Interferon inhibits cardiac cell function in vitro.

Authors:  T J Lampidis; D Brouty-Boyé
Journal:  Proc Soc Exp Biol Med       Date:  1981-02

2.  Deaths halt interferon trials in France.

Authors:  D Dickson
Journal:  Science       Date:  1982-11-19       Impact factor: 47.728

3.  Toxic effects of interferon.

Authors:  R R Oldham
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

Review 4.  Interferons in the treatment of human cancer.

Authors:  J M Kirkwood; M S Ernstoff
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

5.  Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.

Authors:  G T Budd; R M Bukowski; L Miketo; B Yen-Lieberman; M R Proffitt
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Common pathways of interferon and hormonal action.

Authors:  J E Blalock; J D Stanton
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

7.  Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.

Authors:  G Sarna; R Figlin; M Callaghan
Journal:  J Biol Response Mod       Date:  1983

8.  A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer.

Authors:  H B Muss; R A Kempf; S Martino; S A Rudnick; J Greiner; M R Cooper; D Decker; S M Grunberg; D V Jackson; F Richards
Journal:  J Clin Oncol       Date:  1984-09       Impact factor: 44.544

9.  [Clinical trial of human lymphoblastoid interferon on advanced malignancy].

Authors:  N Usui; M Ogawa; J Inagaki; N Horikoshi; K Inoue; H Miyamoto; K Ikeda; H Nakada; K Adachi; Y Okada
Journal:  Gan To Kagaku Ryoho       Date:  1983-11
  9 in total
  1 in total

1.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.